Europe — EMA

Olanzapine Glenmark Europe

Request sourcing

Pack/s

What is Olanzapine?

Olanzapine, the active ingredient in Olanzapine Glenmark Europe, is an atypical antipsychotic presented as a 10 mg tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olanzapine Glenmark Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olanzapine Glenmark Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olanzapine used for?

Olanzapine is an atypical antipsychotic that modulates the psychotic pathways of the brain .

- Schizophrenia: Achieves the control of positive and negative symptoms. - B b bipolar disorder type I Man ‑ st st st "). - " " " "" " "" " "" " " "" " " " "" "

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →